Replies to post #216 on Equity Field Notes from temporal sources

[DanWebzster]

NTEC has two promising assets including a Ph3 Parkinsons drug and a Ph1 CBD preparation for Fibromyalgia

NTEC also has a partnership with NVS to enhance delivery of an undisclosed compound.

The next major milestone will be the Ph3 readout in mid/19 for the treatment of severe Parkinson's symptoms.

4/30/18 Cash runway into 2020.